cjc-1295 & ipamorelin peptide blend / CJC1295 No Dac + Ipamorelin

Ipamorelin has only a handful of human studies, primarily pharmacokinetic trials and a discontinued Phase II for postoperative ileus, making its widespread popularity largely based on animal data

Approved medical uses include: Growth hormone deficiency HIV-related wasting Short stature in children However, using HGH for performance enhancement, anti-aging, or physique goals is not approved by the FDA and is considered illegal

Research focuses on the combined signalling of both pathways in study models

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse